ARID5A
AT-rich interactive domain-containing protein 5A
Also known as: ARI5A_HUMAN, MRF-1, RP11-363D14
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q03989
- Gene
- ARID5A
- Ensembl
- ENSG00000196843
- Chromosome
- 2
- Canonical length
- 594 aa
- Protein class
- Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nucleoplasm,Nucleoli
OverviewNCBI Gene
Members of the ARID protein family, including ARID5A, have diverse functions but all appear to play important roles in development, tissue-specific gene expression, and regulation of cell growth (Patsialou et al., 2005 [PubMed 15640446]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
594 residues, UniProt reviewed canonical sequence.
>Q03989|ARID5A
1 MAAPVKGNRK QSTEGDALDP PASPKPAGKQ NGIQNPISLE DSPEAGGERE EEQEREEEQA
61 FLVSLYKFMK ERHTPIERVP HLGFKQINLW KIYKAVEKLG AYELVTGRRL WKNVYDELGG
121 SPGSTSAATC TRRHYERLVL PYVRHLKGED DKPLPTSKPR KQYKMAKENR GDDGATERPK
181 KAKEERRMDQ MMPGKTKADA ADPAPLPSQE PPRNSTEQQG LASGSSVSFV GASGCPEAYK
241 RLLSSFYCKG THGIMSPLAK KKLLAQVSKV EALQCQEEGC RHGAEPQASP AVHLPESPQS
301 PKGLTENSRH RLTPQEGLQA PGGSLREEAQ AGPCPAAPIF KGCFYTHPTE VLKPVSQHPR
361 DFFSRLKDGV LLGPPGKEGL SVKEPQLVWG GDANRPSAFH KGGSRKGILY PKPKACWVSP
421 MAKVPAESPT LPPTFPSSPG LGSKRSLEEE GAAHSGKRLR AVSPFLKEAD AKKCGAKPAG
481 SGLVSCLLGP ALGPVPPEAY RGTMLHCPLN FTGTPGPLKG QAALPFSPLV IPAFPAHFLA
541 TAGPSPMAAG LMHFPPTSFD SALRHRLCPA SSAWHAPPVT TYAAPHFFHL NTKLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ARID5A can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.66
- Highest tissue expression
- 79 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 79 nTPM
- lung: 46 nTPM
- breast: 39 nTPM
- fallopian tube: 32 nTPM
- adipose tissue: 31 nTPM
- heart muscle: 27 nTPM
Single-cell type
- smooth muscle cells: 271 nCPM
- neutrophils: 220 nCPM
- breast secretory cells: 209 nCPM
- vascular smooth muscle cells: 141 nCPM
- vascular endothelial cells: 136 nCPM
- schwann cells: 128 nCPM
Immune cell
- eosinophil: 33 nTPM
- NK-cell: 28 nTPM
- neutrophil: 22 nTPM
- plasmacytoid DC: 19 nTPM
- T-reg: 16 nTPM
- gdT-cell: 15 nTPM
Brain region
- medulla oblongata: 21 nTPM
- pons: 16 nTPM
- midbrain: 14 nTPM
- spinal cord: 14 nTPM
- thalamus: 13 nTPM
- cerebral cortex: 12 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.35
- gnomAD pLI
- 0.95
- gnomAD missense Z
- 1.67
- DepMap mean gene effect
- -0.26
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to estrogen stimulus
- cellular response to lipopolysaccharide
- chondrocyte differentiation
- innate immune response
- negative regulation of DNA-templated transcription
- negative regulation of transcription by RNA polymerase II
- positive regulation of 3'-UTR-mediated mRNA stabilization
- positive regulation of interleukin-17 production
- positive regulation of interleukin-6 production
- positive regulation of T-helper 1 cell cytokine production
- positive regulation of T-helper 17 type immune response
- positive regulation of transcription by RNA polymerase II
- positive regulation of tumor necrosis factor production
- positive regulation of type II interferon production
- regulation of transcription by RNA polymerase II
Molecular functions
- chromatin binding
- DNA binding
- identical protein binding
- mRNA 3'-UTR AU-rich region binding
- nuclear androgen receptor binding
- nuclear estrogen receptor binding
- nuclear retinoid X receptor binding
- nuclear thyroid hormone receptor binding
- RNA stem-loop binding
- sequence-specific DNA binding
- transcription cis-regulatory region binding
- transcription corepressor activity
- transcription factor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ARID5A in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ARID5A as an antibody target. Whether an autoantibody or antibody against ARID5A could matter depends on whether native ARID5A is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ARID5A is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ARID5A as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...